Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC)
-
Avere Therapeutics raises $500M in private placement for drug program
-
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
-
Form SCHEDULE 13G/A MNTN, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Heartflow, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A TREX CO INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A REDWOOD TRUST INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A National Vision Holdings Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A First Western Financial Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
-
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
-
Franklin Templeton names new product and Asia Pacific heads
-
Franklin Templeton Expands Global Client Group Leadership to Accelerate Next Phase of Growth
-
Form D/A Wellington Management
-
Obsidian Therapeutics completes Galera merger, raises $350M
-
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
-
Synlogic and Caldera Therapeutics agree to all-stock merger
-
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
-
Emerging markets stare at inflation risks as powerful El Niño looms
-
Lumafield Introduces Mars In-line Arrayed X-ray System for 100% Production Inspection
-
Wellington, Vanguard, Blackstone launch funds targeting wealthy investors
-
Wellington, Vanguard, and Blackstone launch two public-private funds
-
Wellington, Vanguard, and Blackstone Announce the Launch of Two Investment Solutions, Simplifying Access to Public and Private Markets
-
Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
-
EXL adds former KPMG UK chair to board, names new lead director
-
EXL announces appointment of Bina Mehta to Board of Directors and lead director transition
-
FalconX Acquires bloXroute to Accelerate the Future of Onchain Capital Markets
-
NextCure and Avere to merge, targeting oral IL-23 therapy
-
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
-
Form SCHEDULE 13G/A Excelerate Energy, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A US Foods Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Eagle Energy Partners Appoints Institutional Capital Markets Veteran Daniel Fugiel to Board of Directors
-
Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
FORE Biotherapeutics Announces Closing of Upsized $67.4 Million Series D-2 Extension Financing and Highlights Recent Plixorafenib Achievements
-
Form D/A Wellington Management
-
JOHN HANCOCK DIVERSIFIED INCOME FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
Higharc Raises $95M Series C to Scale AI for Homebuilding
-
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
-
FalconX Receives MiCA Authorization, Expanding Regulated Institutional Digital Asset Services Across the European Union
-
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
-
AI startup Baseten hits $13 billion valuation as Australia's Blackbird makes record bet
-
T. ROWE PRICE ANNOUNCES STRATEGIC ENHANCEMENTS TO U.S. INSTITUTIONAL BUSINESS
-
Baseten Raises $1.5 Billion to Power the Next Era of AI Inference
-
Lumafield Introduces Neptune Performance and Triton Performance Connecting Metrology-Grade Measurement to Production-Line Inspection
-
Bybit Launches RWA Earn, Bringing Institutional Investment Opportunities On-Chain to Eligible Users
-
Current Secures $80 Million Series E at $1.5 Billion Valuation Following Third Consecutive Year of 70%+ Growth
-
Climate First Bancorp Closes New $67 Million Strategic Funding Round
-
NinjaOne raises $400 million at $12.3 billion valuation

